000 01050nam  2200229za 4500
0019.699195
003CaOODSP
00520180223090752
007cr |||||||||||
008150407s2014||||xxc|||||o    f|0| 0 eng d
020 |a978-1-100-23516-5
040 |aCaOODSP|beng
043 |an-cn---
0861 |aHP40-104/2014E-PDF
1101 |aCanada. |bPublic Health Agency of Canada.
24510|aAdvice for the use of the multicomponent meningococcal serogroup B (4CMenB) vaccine : |h[electronic resource]
2461 |iAt head of title: |aAdvisory Committee Statement (ACS), National Advisory Committee on Immunization
260 |aOttawa - Ontario : |bPublic Health Agency of Canada |cApril 2014.
300 |a43p.|bgraphs, references, tables
590 |a14-16|b2014-04-17
77508|tConseils relatifs à l'utilisation du vaccin multicomposant contre le méningocoque du sérogroupe B (4CMenB) |w(CaOODSP)9.643156
85640|ahttp://publications.gc.ca|qPDF|s664 KB|uhttp://publications.gc.ca/collections/collection_2014/aspc-phac/HP40-104-2014-eng.pdf